Idenix Pharmaceuticals logo
Idenix Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
December 05, 2012 16:05 ET | Idenix Pharmaceuticals
CAMBRIDGE, Mass., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the Oppenheimer 23rd Annual...
Idenix Pharmaceuticals logo
Idenix Pharmaceuticals to Present at the 2012 Deutsche Bank Access BioFEST Conference
November 26, 2012 16:05 ET | Idenix Pharmaceuticals
CAMBRIDGE, Mass., Nov. 26, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present in a fireside chat at the 2012 Deutsche Bank Access...
Idenix Pharmaceuticals logo
Idenix Pharmaceuticals Reports Clinical Data for HCV Drug Candidates - IDX719 and IDX184 - at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
November 10, 2012 09:05 ET | Idenix Pharmaceuticals
CAMBRIDGE, Mass., Nov. 10, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals logo
Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2012 Financial Results and HCV Program Update
November 01, 2012 16:05 ET | Idenix Pharmaceuticals
CAMBRIDGE, Mass., Nov. 1, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals logo
Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2012 Financial Results and HCV Program Update
October 25, 2012 16:05 ET | Idenix Pharmaceuticals
CAMBRIDGE, Mass., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc., (Nasdaq:IDIX) announced today that it will report its financial results for the third quarter of 2012 on Thursday,...
Idenix Pharmaceuticals logo
Idenix Pharmaceuticals to Present at the UBS Global Life Sciences Conference
September 13, 2012 16:05 ET | Idenix Pharmaceuticals
CAMBRIDGE, Mass., Sept. 13, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the UBS Global Life Sciences...
Idenix Pharmaceuticals logo
Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences
August 29, 2012 16:05 ET | Idenix Pharmaceuticals
CAMBRIDGE, Mass., Aug. 29, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), announced today that Idenix management will participate in a panel discussion at Citigroup's 7th Annual...
Idenix Pharmaceuticals logo
Idenix Provides Update on IDX19368 Development Program
August 27, 2012 08:30 ET | Idenix Pharmaceuticals
CAMBRIDGE, Mass., Aug. 27, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals logo
Idenix Provides Update on IDX184 Clinical Development Program
August 16, 2012 08:00 ET | Idenix Pharmaceuticals
IDX184 has been placed on partial clinical hold by FDA Management to host a conference call webcast today at 8:30 am ET CAMBRIDGE, Mass., Aug. 16, 2012 (GLOBE NEWSWIRE) -- Idenix...
Idenix Pharmaceuticals logo
Idenix Pharmaceuticals to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
August 09, 2012 08:30 ET | Idenix Pharmaceuticals
CAMBRIDGE, Mass., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the 2012 Wedbush PacGrow...